Preliminary Study Results Suggested that New HIV/AIDS Drug, Sustiva (efavirenz), is effective when used with Zerit (stavudine) and Epivir (lamivudine)

For full access to this item, please log in.
Title
Preliminary Study Results Suggested that New HIV/AIDS Drug, Sustiva (efavirenz), is effective when used with Zerit (stavudine) and Epivir (lamivudine)
Author
Bristol-Myers Squibb Company
Publication
1999-03-22
Rights/Permissions

The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.

Subject terms
press releases
Series/Folder Title
Disease Management > AIDS Treatment > Pharmaceutical Treatment > General
Item type:
press releases
Link to this Item
https://quod.lib.umich.edu/c/cohenaids/5571095.0291.054
Cite this Item
"Preliminary Study Results Suggested that New HIV/AIDS Drug, Sustiva (efavirenz), is effective when used with Zerit (stavudine) and Epivir (lamivudine)." In the digital collection Jon Cohen AIDS Research Collection. https://quod.lib.umich.edu/c/cohenaids/5571095.0291.054. University of Michigan Library Digital Collections. Accessed May 11, 2025.

Contents

Do you have questions about this content? Need to report a problem? Please contact us.